NORNICOTINE CONTRIBUTION TO THE CNS EFFECT OF NICOTINE
NORNICOTINE CONTRIBUTION TO THE CNS EFFECT OF NICOTINE
批准号:
2013185
负责人:
Linda P Dwoskin
金额:
$15.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-10 至 2000-01-31
关键词:
behavioral habituation /sensitization brain metabolism dopamine drug metabolism laboratory rat neurochemistry neuropharmacology neurotransmitter antagonist neurotransmitter metabolism neurotransmitter transport nicotine nicotinic receptors pharmacokinetics psychopharmacology radiotracer receptor expression tissue /cell culture
中文摘要
描述:(申请人摘要)
吸烟是头号健康问题,占比更大
疾病和死亡比任何其他单一因素都要多。的滥用责任
烟草中的主要生物碱尼古丁(NIC)源于其固有的
增强性能被认为是多巴胺激活的结果
(DA)大脑中的通路。阐明NIC的作用机制和
确定长期服药的效果对于
了解吸烟行为的开始/维持,并为
克服吸烟者在消除这种行为方面遇到的问题。
考虑到关于NIC外周代谢的过多信息,
对NIC在大脑中的新陈代谢及其潜在的作用知之甚少
NIC代谢物的药理活性。这样做的总体目标是
建议对NIC导致的CNS效应的假设进行检验
在使用烟草期间接触烟草并不完全是由于NIC,而是至少导致
部分来自NIC代谢物的作用。我们最近证明了
NIC代谢物(可替宁、去甲烟碱(NorNIC)、去甲可替宁和An迄今
未知的第四代谢物)在急性发作后4小时出现在大脑中
外设[2‘-14C]网卡管理。此外,我们还发现NorNIC
增加超融合大鼠纹状体脑片中DA的释放
依赖于浓度,依赖于钙离子,对甲基胺敏感,
二氢-β-红景天碱敏感和立体选择性方式,表明
烟碱受体调节。同样类似于NIC,重复S(-)或
R(+)NorNIC给药能够激活神经机制(S)
负责行为敏感化,即使R(+)NorNIC没有产生
反复给药后出现明显的行为效应。建议数
该项目将确定NIC代谢物在
脑,药理活性和
NIC代谢物的作用机制及其时间依赖行为
以及神经化学变化对重复使用NorNIC的反应。
建议的研究结果将增加我们对
神经行为效应的分子机制
由烟草使用和NIC暴露引起的。
英文摘要
DESCRIPTION: (Applicant's Abstract)
Cigarette smoking is the number one health problem accounting for more
illnesses and deaths than any other single factor. The abuse liability of
the major tobacco alkaloid, nicotine (NIC), stems from its intrinsic
reinforcing properties suggested to be the result of activation of dopamine
(DA) pathways in brain. Elucidation of NIC's mechanism of action and
determination of the effects of chronic administration are important for
understanding the initiation/maintenance of smoking behavior, and for
overcoming problems that smokers experience in extinguishing this behavior.
Considering the plethora of information on the peripheral metabolism of NIC,
little is known about NIC metabolism in brain and about the potential
pharmacologic activity of NIC metabolites. The overall objective of this
proposal is to test the hypothesis that CNS effects resulting from NIC
exposure during tobacco usage are not solely due to NIC, but result at least
in part from actions of NIC metabolites. We have recently demonstrated that
NIC metabolites (cotinine, nornicotine (norNIC), norcotinine, and an as yet
unidentified fourth metabolite) are present in brain 4 hours after acute
peripheral [2'-14C]NIC administration. Also, we have found that norNIC
increases DA release from superfused rat striatal slices in a
concentration-dependent, Ca++ -dependent, mecamylamine-sensitive,
dihydro-beta-erythroidine-sensitive, and stereo-selective manner, indicating
nicotinic receptor mediation. Also similar to NIC, repeated S(-) or
R(+)norNIC administration were capable of activating the neural mechanism(s)
responsible for behavioral sensitization, even though R(+)norNIC produced no
overt behavioral effects after its repeated administration. The proposed
project will determine the kinetics of accumulation of NIC metabolites in
brain, the pharmacological activity and
mechanism of action of NIC metabolites, and the time-dependent behavioral
and neurochemical changes in response to repeated norNIC administration.
The results of the proposed studies will increase our knowledge of the
molecular mechanisms that are involved in the neurobehavioral effects
resulting from tobacco use and NIC exposure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kentucky Network for Innovation & Commercialization (“KYNETIC”)
-
批准号:10475211
-
项目类别:
-
资助金额:$95.82万
-
财政年份:2019
-
负责人:Linda P Dwoskin
-
依托单位:
Development of Novel Therapeutics for Methamphetamine Abuse
-
批准号:10186610
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2018
-
负责人:Linda P Dwoskin
-
依托单位:
Development of Novel Therapeutics for Methamphetamine Abuse
-
批准号:9750673
-
项目类别:
-
资助金额:$83.92万
-
财政年份:2018
-
负责人:Linda P Dwoskin
-
依托单位:
Development of Antagonists for M5 Muscarinic Acetylcholine Receptor
-
批准号:7768413
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2009
-
负责人:Linda P Dwoskin
-
依托单位:
Development of Novel Therapies or Methamphetamine Abuse
-
批准号:7829875
-
项目类别:
-
资助金额:$102.77万
-
财政年份:2009
-
负责人:Linda P Dwoskin
-
依托单位:
Nicotinic Receptor Regulation of Dopamine Transporter
-
批准号:6989377
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2005
-
负责人:Linda P Dwoskin
-
依托单位:
Nicotinic Receptor Regulation of Dopamine Transporter
-
批准号:7140559
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2005
-
负责人:Linda P Dwoskin
-
依托单位:
Training in Drug Abuse Related Research
-
批准号:9297250
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2004
-
负责人:Linda P Dwoskin
-
依托单位:
Training in Drug Abuse Related Research
-
批准号:8286390
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2004
-
负责人:Linda P Dwoskin
-
依托单位:
Training in Drug Abuse Related Research
-
批准号:7821333
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2004
-
负责人:Linda P Dwoskin
-
依托单位:
Training in Drug Abuse Related Research
-
批准号:8484371
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2004
-
负责人:Linda P Dwoskin
-
依托单位:
Training in Drug Abuse Related Research
-
批准号:8874398
-
项目类别:
-
资助金额:$9.44万
-
财政年份:2004
-
负责人:Linda P Dwoskin
-
依托单位:
Training in Drug Abuse Related Research
-
批准号:8091401
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2004
-
负责人:Linda P Dwoskin
-
依托单位:
Developmemt of Novel Treatments for Nicotine Addiction
-
批准号:6695850
-
项目类别:
-
资助金额:$102.91万
-
财政年份:2003
-
负责人:Linda P Dwoskin
-
依托单位:
Developmemt of Novel Treatments for Nicotine Addiction
-
批准号:6806074
-
项目类别:
-
资助金额:$111.49万
-
财政年份:2003
-
负责人:Linda P Dwoskin
-
依托单位:
Developmemt of Novel Treatments for Nicotine Addiction
-
批准号:7082960
-
项目类别:
-
资助金额:$128.91万
-
财政年份:2003
-
负责人:Linda P Dwoskin
-
依托单位:
Developmemt of Novel Treatments for Nicotine Addiction
-
批准号:6920034
-
项目类别:
-
资助金额:$126.28万
-
财政年份:2003
-
负责人:Linda P Dwoskin
-
依托单位:
Developmemt of Novel Treatments for Nicotine Addiction
-
批准号:7262407
-
项目类别:
-
资助金额:$129.03万
-
财政年份:2003
-
负责人:Linda P Dwoskin
-
依托单位:
DEVELOPMENT OF NOVEL THERAPIES FOR METHAMPHETAMINE ABUSE
-
批准号:6640819
-
项目类别:
-
资助金额:$33.97万
-
财政年份:2000
-
负责人:Linda P Dwoskin
-
依托单位:
Development of Novel Therapies or Methamphetamine Abuse
-
批准号:7284372
-
项目类别:
-
资助金额:$53.16万
-
财政年份:2000
-
负责人:Linda P Dwoskin
-
依托单位:
海外基金